Back to Results
First PageMeta Content
Amines / Quinazolines / AstraZeneca / Gefitinib / Morpholines / Adverse effect / Erlotinib / Chemistry / Organic chemistry / Organofluorides


NDA[removed]S-003 Page 3 Rev[removed]
Add to Reading List

Document Date: 2009-03-31 15:48:48


Open Document

File Size: 205,56 KB

Share Result on Facebook

Company

Disease Characteristics Characteristic Age Group / /

Country

United States / /

Event

FDA Phase / /

IndustryTerm

treatment for an IRESSA overdose and possible symptoms / food / treatment of non-small cell lung cancer / /

MedicalCondition

tumor / cancer / lymphoma / acne / tumors / disease / NSCLC / dyspnea / shortness of breath / Carcinogenesis / interstitial pneumonia / dysfunction / cerebral hemorrhage / nausea / skin rash / toxic epidermal necrolysis / fever / pulmonary fibrosis / hepatic metastases / conjunctivitis / vomiting / amblyopia / pulmonary / urticaria / angioedema / pancreatitis / allergic reactions / erythema multiforme / diarrhea / hypersensitivity / irritation / cough / Pruritus / metastases / pneumonitis / rash / interstitial lung disease / adenocarcinoma / dehydration / /

MedicalTreatment

radiation therapy / chemotherapy / chemotherapies / radiation / /

Organization

World Health Organization / Patients and DOSAGE AND ADMINISTRATION / DOSAGE AND ADMINISTRATION / /

Product

carboplatin / phenytoin / itraconazole / ranitidine / PHARMACOLOGYPharmacokinetics-Drug / paclitaxel / polyethylene glycol / acetic acid / sodium bicarbonate / ketoconazole / IRESSA / cimetidine / S-003 / /

PublishedMedium

the Japanese post / /

Technology

Pharmacokinetics / radiation / chemotherapy / /

SocialTag